FDA approves new drug for Alzheimer’s disease: ‘Meaningful results’

The U.S. Food and Drug Administration has approved a new medication for people with Alzheimer’s disease.

Eli Lilly’s Kisunla is a once-monthly injection intended for adults with early symptomatic Alzheimer's disease, according to a press release from the company. Eligible patients include those with mild cognitive impairment and those who have mild dementia with confirmed amyloid pathology. This is the first medication to target amyloid plaques — the proteins that build up in the brains of Alzheimer’s patients, often impairing memory and cognitive function — with evidence to support stopping...Thank you! Community votes alone don't determine our ratings, but are valuable feedback and can prompt us to do more research.that highlights survey data on topics on which Americans largely agree.

Could the FDA ban chemical in decaf coffee? Agency is looking into whether substance used by Starbucks and Dunkin' Donuts to strip out caffeine may cause CANCER

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA approves new drug for Alzheimer’s disease: ‘Meaningful results’The FDA has approved a new medication for people with Alzheimer’s disease. Eli Lilly’s Kisunla (donanemab) is a once-monthly injection intended for adults with early symptomatic Alzheimer's disease.
Source: FoxNews - 🏆 9. / 87 Read more »